VIVO VENTURES VII, LLC [Rocket]

Date Filed	Type	Description
11/01/2021	SC 13G	VIVO VENTURES VII, LLC reports a 7.8% stake in Minerva Surgical, Inc.
10/23/2019	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2019	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/02/2018	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/16/2017	SC 13D/A	VIVO VENTURES VII, LLC has filed a Schedule 13D for Aclaris Therapeutics, Inc.
10/20/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/25/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/14/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/10/2017	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/03/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
02/13/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
11/21/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
06/20/2016	SC 13D/A	Ascendis Pharma A/S reports a 6.9% stake in Ascendis Pharma A/S
06/03/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
04/22/2016	SC 13D/A	VIVO VENTURES VII, LLC reports a 5% stake in MEI Pharma, Inc.
04/15/2016	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/07/2016	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
03/10/2016	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
12/21/2012	SC 13D	VIVO VENTURES VII, LLC reports a 33% stake in MEI Pharma, Inc.